BDNF Stimulation of Protein Synthesis in Cortical Neurons Requires the MAP Kinase-Interacting Kinase MNK1

Abstract

Although the MAP kinase-interacting kinases (MNKs) have been known for Ͼ15 years, their roles in the regulation of protein synthesis have remained obscure. Here, we explore the involvement of the MNKs in brain-derived neurotrophic factor (BDNF)-stimulated protein synthesis in cortical neurons from mice. Using a combination of pharmacological and genetic approaches, we show that BDNF-induced upregulation of protein synthesis requires MEK/ERK signaling and the downstream kinase, MNK1, which phosphorylates eukaryotic initiation factor (eIF) 4E. Translation initiation is mediated by the interaction of eIF4E with the m 7 GTP cap of mRNA and with eIF4G. The latter interaction is inhibited by the interactions of eIF4E with partner proteins, such as CYFIP1, which acts as a translational repressor. We find that BDNF induces the release of CYFIP1 from eIF4E, and that this depends on MNK1. Finally, using a novel combination of BONCAT and SILAC, we identify a subset of proteins whose synthesis is upregulated by BDNF signaling via MNK1 in neurons. Interestingly, this subset of MNK1-sensitive proteins is enriched for functions involved in neurotransmission and synaptic plasticity. Additionally, we find significant overlap between our subset of proteins whose synthesis is regulated by MNK1 and those encoded by known FMRP-binding mRNAs. Together, our data implicate MNK1 as a key component of BDNF-mediated translational regulation in neurons.

Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome

“…Mutations in several of the FMRP target mRNAs are associated with different forms of intellectual disability such as ASD, mood disorders, and schizophrenia (Pasciuto and Bagni, 2014b). A mechanism through which FMRP inhibits translation of synaptic mRNAs is via the cytoplasmic FMRP interacting protein 1 (CYFIP1) that acts as an eIF4E-binding protein (De Rubeis et al, 2013;Genheden et al, 2015;Napoli et al, 2008;Panja et al, 2014). Among the bona-fide mRNAs regulated by FMRP (Pasciuto and Bagni, 2014b) is the transcript encoding the amyloid precursor protein (APP) (Napoli et al, 2008;Westmark and Malter, 2007).…”

BONLAC: A combinatorial proteomic technique to measure stimulus-induced translational profiles in brain slices

“…BONLAC addresses these concerns by allowing for a direct quantitative comparison of newly synthesized proteins on a short timescale. It had previously been used in human CD4+ cells 10 , HEK-TrkB cells 12 , and recently, cultured neurons 38 . However, it has never been adapted for use in three dimensional tissue systems.…”

Dysregulation and restoration of translational homeostasis in fragile X syndrome

“…Thus, the activity of the FMRP–CYFIP1 complex, through an as-yet-unknown mechanism, can switch between translational control and actin remodelling 34 . It has been shown that activation of either brain-derived neurotrophic factor (BDNF) or group 1 metabotropic glutamate receptor (mGluR) signalling can release CYFIP1 from eIF4E (but not CYFIP1 from FMRP) to promote translation 33,35 . This activation is consistent with the observation that the involvement of the FMRP–CYFIP1 complex in long-lasting synaptic plasticity is controlled by MNK1 and/or MNK2 (REF.…”